Evidence map›Paper›PMID 40849887›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2025

RACK1 is required for normal B cell development and signaling but not RAG1 degradation.

Victoria L Palmer, N Max Schabla, Vikas Kumar, Patrick C Swanson

Abstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Victoria L PalmerDepartment of Medical Microbiology and Immunology, Creighton University, Omaha, NE, United States.
N Max SchablaDepartment of Medical Microbiology and Immunology, Creighton University, Omaha, NE, United States.
Vikas KumarDepartment of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, NE, United States.ORCID 0000-0001-7513-6832
Patrick C SwansonDepartment of Medical Microbiology and Immunology, Creighton University, Omaha, NE, United States.ORCID 0000-0002-3290-6582

Funding

Understanding the progression of hearing loss in an endolymphatic hydrops modelP20GM139762 · NIGMS · CREIGHTON UNIVERSITY · PI Justine Marie Renauld · 2021 to 2026
$16.1M
CONSTRUCTION OF RESEARCH FACILITYC06RR017417 · NCRR · CREIGHTON UNIVERSITY · PI WILSON, M. ROY · 2002 to 2002
$2.0M
Role of VprBP in B cell development and V(D)J recombinationR01GM102487 · NIGMS · CREIGHTON UNIVERSITY · PI SWANSON, PATRICK C. · 2012 to 2015
$1.2M
Replacing an Animal Resource Facility Cage Washer.G20RR024001 · NCRR · CREIGHTON UNIVERSITY · PI DRESCHER, KRISTEN · 2007 to 2007
$638k
Role of RACK1 in RAG1 degradation and B cell developmentR21AI153688 · NIAID · CREIGHTON UNIVERSITY · PI SWANSON, PATRICK C. · 2021 to 2022
$400k
Auditory and Vestibular Technology Core FacilityAuditory and Vestibular Technology Core Facility SCR_023866Bio-Rad ZE5 Cell Analyzer GM102487-03S1Bio-Rad ZE5 Cell Analyzer GM139762-04S1Boys Town National Research HospitalCreighton UniversityCreighton University Animal Resource Facility G20RR024001Flow Cytometry Core FacilityInvitrogen Bigfoot GM139762-04S1National Institute of General Medical ScienceNCRR NIH HHS C06 RR017417NCRR NIH HHS G20 RR024001Nebraska Department of Health and Human ServicesNIAID NIH HHS R21 AI153688NIGMS NIH HHS P20 GM139762NIGMS NIH HHS R01 GM102487NIHNIH HHS 1R21AI153688NIH HHS C06 RR17417-01State of NebraskaTranslational Hearing CenterUniversity of Nebraska Medical Center GM139762
6 · The paper itself

Abstract

V(D)J recombination is constrained by timely degradation of the RAG1 and RAG2 proteins through distinct mechanisms. Previously, we showed that full-length RAG1 stability is regulated by viral protein R binding protein (VprBP) through its association with an amino-terminal region in RAG1, but the mechanism remains unclear. As an unbiased approach to uncover potential cofactors involved in the process, we compared protein interactomes between RAG1/RAG2 complexes formed when the amino-terminal third of RAG1 was present or absent. These experiments identified RACK1 as preferentially associating with full-length RAG1. Because RACK1 is implicated in mediating protein degradation in other contexts, we evaluated how loss of RACK1 in B cells affects B cell development and V(D)J recombination. We find that conditional disruption of Rack1 expression in the B lineage in mice blocks B cell development at the pro-B cell stage and impairs V(D)J recombination after Igh DH-JH rearrangement. In this background, enforced Bcl2 expression does not significantly rescue B cell development but does enable the V(D)J recombination defect to be bypassed. However, the phenotype of these mice does not show the excessive Igk rearrangement, skewing toward Igλ+ B cells, or increased RAG1 protein levels observed when VprBP expression is similarly disrupted in B cells, arguing against RACK1 serving as a cofactor in RAG1 degradation. Further studies provide evidence that loss of RACK1 in primary B cells dysregulates cell cycle progression, apoptosis, proliferation, and signaling through MAPK and NF-κB pathways.

Indexed as

B-LymphocytesGTP-Binding ProteinsHomeodomain ProteinsNeoplasm ProteinsReceptors, Cell SurfaceSignal TransductionAnimalsCell DifferentiationDNA-Binding ProteinsMiceMice, Inbred C57BLMice, KnockoutProteolysisProto-Oncogene Proteins c-bcl-2Receptors for Activated C KinaseV(D)J RecombinationDNA-Binding ProteinsGTP-Binding ProteinsHomeodomain ProteinsNeoplasm ProteinsProto-Oncogene Proteins c-bcl-2RACK1 protein, mouseRAG-1 proteinRag2 protein, mouseReceptors, Cell SurfaceReceptors for Activated C KinaseB cell developmentB cell signalingRACK1Src kinaseV(D)J recombination

Identifiers

PMID40849887
PMCPMC12380162

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.